Stock listing

CTSO Stock Price, News, Filings & Events — Cytosorbents Corporation

Selected listing: CTSO · BOATS · USD · US

This page tracks Cytosorbents Corporation's CTSO:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CTSO:BOATS. CTSO:BOATS is the stock-level entry point for investors researching Cytosorbents Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytosorbents Corporation, trading under the ticker CTSO, is a public company based in America with a market capitalization of approximately $22.6 million. The company focuses on developing innovative therapies to treat critical illnesses using its proprietary blood purification technology. Cytosorbents aims to improve patient outcomes through its advanced medical solutions.

CTSO:BOATSUSDUSUpdated August 28, 2026
Cytosorbents Corporation logo
Ticker
CTSO:BOATS
Asset type
Stock
Market cap
$21.1M
Sector
Health Technology
Industry
Medical Specialties
Exchange
BOATS
Currency
USD

Cytosorbents Corporation CTSO:BOATS stock context

This page tracks Cytosorbents Corporation's CTSO:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CTSO:BOATS. CTSO:BOATS is the stock-level entry point for investors researching Cytosorbents Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytosorbents Corporation, trading under the ticker CTSO, is a public company based in America with a market capitalization of approximately $22.6 million. The company focuses on developing innovative therapies to treat critical illnesses using its proprietary blood purification technology. Cytosorbents aims to improve patient outcomes through its advanced medical solutions.

Latest news from Cytosorbents Corporation

All Cytosorbents Corporation news →

Cytosorbents Corporation earnings calls

Research Cytosorbents Corporation

Alternate listings